CTNM 8-K 2026-09-14

Contineum Therapeutics, Inc. (CTNM) 8-K dated 2026-09-14 — accession 0001628280-26-061834. This URL is the filing, not the CTNM hub.

Contineum Therapeutics, Inc. (CTNM) is a biotechnology company listed on US.

Contineum Therapeutics, Inc. filed a 8-K on 2026-09-14. Accession 0001628280-26-061834.

Cached items: 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported CTNM revenue for 2024-12-31 was $0. Net income was -$42.3M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. CTNM currently screens at market cap $429.6M.

Not investment advice. The CTNM SEC hub lists recent forms. The stock page is the research view.